Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Line Ledsgaard

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Toxins|June 13, 2018
Basics of Antibody Phage Display TechnologyLine Ledsgaard, Mogens Kilstrup, Aneesh Karatt-Vellatt, et al.
Toxicon : Official Journal of the International Society on Toxinology|June 8, 2019
Engineering and design considerations for next-generation snakebite antivenomsCecilie Knudsen, Line Ledsgaard, Rasmus Ibsen Dehli, et al.
Protein Science : a Publication of the Protein Society|April 28, 2022
Synthetic antibodies block receptor binding and current-inhibiting effects of α-cobratoxin from Naja kaouthiaShane Miersch, Guillermo de la Rosa, Rasmus Friis, et al.
Frontiers in Immunology|July 30, 2019
History of Envenoming Therapy and Current PerspectivesManuela B Pucca, Felipe A Cerni, Rahel Janke, et al.
Drug Discovery Today|May 13, 2022
Advances in antibody phage display technologyLine Ledsgaard, Anne Ljungars, Charlotte Rimbault, et al.
Frontiers in Immunology|December 2, 2020
Discovery of a Recombinant Human Monoclonal Immunoglobulin G Antibody Against α-Latrotoxin From the Mediterranean Black Widow Spider (<i>Latrodectus tredecimguttatus</i>)Sofie Føns, Line Ledsgaard, Maxim V Nikolaev, et al.
Biochemical Pharmacology|August 21, 2023
An in vitro assay to investigate venom neurotoxin activity on muscle-type nicotinic acetylcholine receptor activation and for the discovery of toxin-inhibitory moleculesRohit N Patel, Rachel H Clare, Line Ledsgaard, et al.
Scientific Reports|July 3, 2020
An in vitro methodology for discovering broadly-neutralizing monoclonal antibodiesShirin Ahmadi, Manuela B Pucca, Jonas A Jürgensen, et al.
Toxins|September 29, 2018
Antibody Cross-Reactivity in Antivenom ResearchLine Ledsgaard, Timothy P Jenkins, Kristian Davidsen, et al.
Iscience|March 21, 2022
Orally active bivalent V<sub>H</sub>H construct prevents proliferation of F4<sup>+</sup> enterotoxigenic <i>Escherichia coli</i> in weaned pigletsBerthe Katrine Fiil, Sandra Wingaard Thrane, Michael Pichler, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Toxins|June 13, 2018
Basics of Antibody Phage Display TechnologyLine Ledsgaard, Mogens Kilstrup, Aneesh Karatt-Vellatt, et al.
Toxicon : Official Journal of the International Society on Toxinology|June 8, 2019
Engineering and design considerations for next-generation snakebite antivenomsCecilie Knudsen, Line Ledsgaard, Rasmus Ibsen Dehli, et al.
Protein Science : a Publication of the Protein Society|April 28, 2022
Synthetic antibodies block receptor binding and current-inhibiting effects of α-cobratoxin from Naja kaouthiaShane Miersch, Guillermo de la Rosa, Rasmus Friis, et al.
Frontiers in Immunology|July 30, 2019
History of Envenoming Therapy and Current PerspectivesManuela B Pucca, Felipe A Cerni, Rahel Janke, et al.
Drug Discovery Today|May 13, 2022
Advances in antibody phage display technologyLine Ledsgaard, Anne Ljungars, Charlotte Rimbault, et al.
Frontiers in Immunology|December 2, 2020
Discovery of a Recombinant Human Monoclonal Immunoglobulin G Antibody Against α-Latrotoxin From the Mediterranean Black Widow Spider (<i>Latrodectus tredecimguttatus</i>)Sofie Føns, Line Ledsgaard, Maxim V Nikolaev, et al.
Biochemical Pharmacology|August 21, 2023
An in vitro assay to investigate venom neurotoxin activity on muscle-type nicotinic acetylcholine receptor activation and for the discovery of toxin-inhibitory moleculesRohit N Patel, Rachel H Clare, Line Ledsgaard, et al.
Scientific Reports|July 3, 2020
An in vitro methodology for discovering broadly-neutralizing monoclonal antibodiesShirin Ahmadi, Manuela B Pucca, Jonas A Jürgensen, et al.
Toxins|September 29, 2018
Antibody Cross-Reactivity in Antivenom ResearchLine Ledsgaard, Timothy P Jenkins, Kristian Davidsen, et al.
Iscience|March 21, 2022
Orally active bivalent V<sub>H</sub>H construct prevents proliferation of F4<sup>+</sup> enterotoxigenic <i>Escherichia coli</i> in weaned pigletsBerthe Katrine Fiil, Sandra Wingaard Thrane, Michael Pichler, et al.
Pageof 3